Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mechanical Ventilation in Interstitial Lung Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03416075
Recruitment Status : Completed
First Posted : January 30, 2018
Last Update Posted : January 30, 2018
Sponsor:
Information provided by (Responsible Party):
Zujin Luo, Beijing Chao Yang Hospital

Brief Summary:
To identify risk factors for mortality in patients with interstitial lung disease receiving mechanical ventilation.

Condition or disease Intervention/treatment
Interstitial Lung Disease Mechanical Ventilation Risk Factors Morality Device: Mechanical ventilation

Layout table for study information
Study Type : Observational
Actual Enrollment : 94 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Risk Factors for Mortality in Patients With Interstitial Lung Disease Receiving Mechanical Ventilation: A Retrospective, Observational Cohort Study
Actual Study Start Date : January 1, 2011
Actual Primary Completion Date : December 31, 2017
Actual Study Completion Date : December 31, 2017

Resource links provided by the National Library of Medicine



Intervention Details:
  • Device: Mechanical ventilation
    Noninvasive and/or invasive mechanical ventilation were performed when patients had respiratory failure.


Primary Outcome Measures :
  1. ICU Mortality [ Time Frame: 7 years ]

Secondary Outcome Measures :
  1. Hospital mortality [ Time Frame: 7 years ]
  2. Noninvasive mechanical ventilation failure [ Time Frame: 7 years ]
  3. Invasive mechanical ventilation failure [ Time Frame: 7 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients were diagnosed as interstitial lung disease and received mechanical ventilation.
Criteria

Inclusion Criteria:

  1. They were clearly diagnosed as interstitial lung disease in hospital;
  2. They had progressive worsening of dyspnea and their oxygenation indexes were less than 300 in ICU;
  3. They received at least 48 hours of mechanical ventilation after being admitted into ICU.

Exclusion Criteria:

  • We excluded patients who were admitted into ICU because of postoperative monitoring.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03416075


Sponsors and Collaborators
Beijing Chao Yang Hospital
Investigators
Layout table for investigator information
Principal Investigator: Zujin Luo, MD Beijing Chao Yang Hospital
Layout table for additonal information
Responsible Party: Zujin Luo, Attending physician, Beijing Chao Yang Hospital
ClinicalTrials.gov Identifier: NCT03416075    
Other Study ID Numbers: BeijingCYH-ICU-006
First Posted: January 30, 2018    Key Record Dates
Last Update Posted: January 30, 2018
Last Verified: January 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Lung Diseases
Lung Diseases, Interstitial
Respiratory Tract Diseases